St. Johns Investment Management’s Globus Medical GMED Stock Holding History

St. Johns Investment Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500	Closed	-$26.8K	–	212
2024 Q1	$26.8K	Hold	500	–	–	0.01%	124
2023 Q4	$26.6K	Hold	500	–	–	0.01%	112
2023 Q3	$24.8K	Hold	500	–	–	0.01%	110
2023 Q2	$29.8K	Hold	500	–	–	0.02%	111
2023 Q1	$28.3K	Hold	500	–	–	0.02%	109
2022 Q4	$37.1K	Hold	500	–	–	0.02%	104
2022 Q3	$30K	Hold	500	–	–	0.02%	108
2022 Q2	$28K	Hold	500	–	–	0.02%	107
2022 Q1	$37K	Hold	500	–	–	0.02%	109
2021 Q4	$36K	Hold	500	–	–	0.02%	113
2021 Q3	$38K	Hold	500	–	–	0.02%	104
2021 Q2	$39K	Hold	500	–	–	0.02%	97
2021 Q1	$31K	Hold	500	–	–	0.02%	98
2020 Q4	$33K	Sell	500 -7,000	-93%	-$402K	0.02%	99
2020 Q3	$371K	Hold	7,500	–	–	0.25%	72
2020 Q2	$358K	Hold	7,500	–	–	0.26%	71
2020 Q1	$319K	Hold	7,500	–	–	0.29%	69
2019 Q4	$442K	Hold	7,500	–	–	0.31%	71
2019 Q3	$383K	Hold	7,500	–	–	0.29%	74
2019 Q2	$317K	Hold	7,500	–	–	0.24%	77
2019 Q1	$371K	Hold	7,500	–	–	0.29%	73
2018 Q4	$325K	Hold	7,500	–	–	0.29%	73
2018 Q3	$426K	Hold	7,500	–	–	0.32%	72
2018 Q2	$378K	Hold	7,500	–	–	0.28%	72
2018 Q1	$374K	Hold	7,500	–	–	0.28%	74
2017 Q4	$308K	Sell	7,500 -653	-8%	-$22.9K	0.23%	75
2017 Q3	$242K	Sell	8,153 -2,113	-21%	-$64.5K	0.18%	78
2017 Q2	$340K	Hold	10,266	–	–	0.26%	76
2017 Q1	$304K	Hold	10,266	–	–	0.24%	76
2016 Q4	$255K	Sell	10,266 -3,300	-24%	-$75K	0.21%	76
2016 Q3	$306K	Hold	13,566	–	–	0.26%	76
2016 Q2	$323K	Sell	13,566 -171	-1%	-$4.1K	0.29%	74
2016 Q1	$326K	Sell	13,737 -110	-0.8%	-$2.69K	0.29%	75
2015 Q4	$385K	Hold	13,847	–	–	0.35%	73
2015 Q3	$286K	Hold	13,847	–	–	0.27%	75
2015 Q2	$355K	Hold	13,847	–	–	0.3%	73
2015 Q1	$349K	Hold	13,847	–	–	0.31%	70
2014 Q4	$329K	Hold	13,847	–	–	0.29%	71
2014 Q3	$272K	Hold	13,847	–	–	0.24%	70
2014 Q2	$331K	Hold	13,847	–	–	0.28%	71
2014 Q1	$368K	Buy	+13,847	New	+$329K	0.33%	69

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

St. Johns Investment Management's GMED Position: Q2 2024 in Review

St. Johns Investment Management sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 500 shares — an estimated $26.8K sold.

St. Johns Investment Management first reported a position in GMED in Q1 2014 and held it in 41 quarters. The position peaked at $442K in Q4 2019. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

St. Johns Investment Management reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
St. Johns Investment Management sold 500 Globus Medical shares in Q2 2024, an estimated $26.8K.
St. Johns Investment Management first reported a position in Globus Medical in Q1 2014 and held it in 41 quarters.
St. Johns Investment Management's Globus Medical position peaked at $442K in Q4 2019.
450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on St. Johns Investment Management's 13F filing for Q2 2024, filed 25 Jul 2024.